The enriched population of IL-10R2+ myeloid cells displaying the TEM signature in the peripheral blood of PDAC patients suggested that these cells are predisposed to migrate from the peripheral blood to PDAC during cancer progression. This evidence concerns the gene IL10RB and cancer.